Ferrochelatase is a therapeutic target for ocular neovascularization

Author:

Basavarajappa Halesha D12,Sulaiman Rania S134,Qi Xiaoping1,Shetty Trupti13,Sheik Pran Babu Sardar1,Sishtla Kamakshi L1,Lee Bit5,Quigley Judith1,Alkhairy Sameerah1,Briggs Christian M1,Gupta Kamna1,Tang Buyun2,Shadmand Mehdi1,Grant Maria B13,Boulton Michael E1,Seo Seung‐Yong5,Corson Timothy W123ORCID

Affiliation:

1. Eugene and Marilyn Glick Eye Institute and Department of Ophthalmology Indiana University School of Medicine Indianapolis IN USA

2. Department of Biochemistry and Molecular Biology Indiana University School of Medicine Indianapolis IN USA

3. Department of Pharmacology and Toxicology Indiana University School of Medicine Indianapolis IN USA

4. Department of Biochemistry Faculty of Pharmacy Cairo University Cairo Egypt

5. College of Pharmacy Gachon University Incheon South Korea

Funder

International Retinal Research Foundation

National Eye Institute

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

JDRF

National Research Foundation of Korea

Research to Prevent Blindness

Carl Marshall and Mildred Almen Reeves Foundation

Ralph W. and Grace M. Showalter Research Trust Fund

National Center for Advancing Translational Sciences

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3